
RenBio
40 posts

RenBio
@RenBioNYC
RenBio is a privately-held, preclinical biotechnology company developing a DNA-based platform technology for delivering antibody and protein therapeutics.




In ep.413 of #AIinAction, @rliberatore, President and Chief Scientific Officer at @RenBioNYC discusses their work withinn #BioTech, the role of #data and new #technology & their work with DARPA's #Pandemic Prevention Platform 🎧Listen now 🔽🔽🔽 bit.ly/3HjIZwM


(1/4) Career news: after an incredible 7 years, I have decided 2 step down from my position as COO & CDO of @RenBioNYC. Launching & growing RenBio has been one of the most rewarding experiences of my career, & now that it’s established & on a clear development path forward, ...











Thrilled to announce 2 new grants awarded to @RenBioNYC from @DARPA @VanderbiltU & @EmpireStateDev. Ready 2 expand our platform to fight infectious disease outbreaks & work alongside phenomenal ID leaders @croweje & @RHCarnahan! #nycbiotech prnewswire.com/news-releases/…






Good overview of NYC's burgeoning biotech scene in @cenmag story. Incl's Alexandria Center, JLabs, Deerfield's Cure space, BioLabs. Kallyope's CEO Nancy Thornbery said they picked NYC over Bay Area & Boston. So did @Jack_O_Meara @OchreBio for US office. cen.acs.org/business/New-Y…




